Black Diamond Therapeutics (BDTX) Stock Price & Financial Analysis
Black Diamond Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Black Diamond Therapeutics
What is the current stock price for BDTX?
As of the latest trading session, BDTX stock trades at $1.82. The 52-week range is $1.78–$4.94, with a day range of $1.78–$1.90.
What is the P/E ratio for BDTX?
Black Diamond Therapeutics's trailing P/E ratio is 4.8, meaning investors pay $4.8 for every $1 of annual earnings. Black Diamond Therapeutics operates in the Healthcare sector.
Does BDTX pay dividends?
Black Diamond Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BDTX?
Based on 2 analysts, the consensus for BDTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BDTX?
Black Diamond Therapeutics's market capitalization is $104.8M, classifying it as a micro-cap company. Black Diamond Therapeutics operates in the Healthcare sector within the Biotechnology industry.